Related Experiment Videos
Technology Development Through Pooling ARV Drug Patents: A Vision from China
1Department of Infectious Disease, Shanghai Public Health Clinical Center Affiliated to Fudan University, Shanghai, 201508, China.
The Open AIDS Journal
|March 13, 2010
Summary
High prices of antiretroviral (ARV) drugs in China limit access for AIDS patients. Strategies like compulsory licensing, patent research, and patent pools can improve affordability and availability of these life-saving medications.
Area of Science:
- Public Health
- Pharmaceutical Policy
- Intellectual Property Law
Background:
- Antiretroviral (ARV) drug prices in China remain a significant barrier to access for individuals living with AIDS.
- Patent protection for ARV drugs has severely restricted their availability to patients in China, impacting public health outcomes.
Purpose of the Study:
- To explore strategies for the Chinese government to overcome existing ARV drug patents.
- To identify methods for increasing the affordability and accessibility of essential AIDS medications.
Main Methods:
- Analysis of patent protection mechanisms for ARV drugs in China.
- Investigation of compulsory licensing and international patent pool frameworks.
- Exploration of government and industry partnerships for ARV drug production.
Main Results:
- Compulsory licensing, technology transfer, and government-backed ARV production facilities are viable options.
- Thorough patent analysis can reveal loopholes to facilitate generic drug entry.
- Patent pools offer a collaborative approach to reduce medication costs.
Conclusions:
- Implementing strategies such as compulsory licensing, patent pool participation, and strategic partnerships can significantly enhance access to affordable ARV drugs in China.
- Proactive patent research and negotiation are crucial for overcoming access barriers.
- Policy interventions are essential to ensure that life-saving AIDS medications reach all patients in need.
Related Concept Videos
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...